Evidence map›Paper›PMID 42352341›Full record

ArticleBiomolecules2026

Bile Acid Dysregulation in Parkinson's Disease: Longitudinal Changes and Altered Metabolic Interactions.

Andrea Ižarik Verešpejová, Marián Grendár, Martin Kertys, Natália Huňarová, Li Sheng Chien, Milan Grofik, Michaela Škorvanová, Jakub Šofranko, Nela Žideková, Egon Kurča and 1 more

Abstract read
In one paragraph

Article in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Andrea Ižarik VerešpejováDepartment of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University, 036 01 Bratislava, Slovakia.ORCID 0009-0008-6474-7492
Marián GrendárBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, 036 01 Bratislava, Slovakia.
Martin KertysDepartment of Pharmacology, Jessenius Faculty of Medicine in Martin, Comenius University Bratislava, 036 01 Bratislava, Slovakia.ORCID 0000-0002-1095-6810
Natália HuňarováDepartment of Medical Biochemistry, Jessenius Faculty of Medicine in Martin, Comenius University, 036 01 Bratislava, Slovakia.
Li Sheng ChienDepartment of Molecular Biology, Faculty of Natural Sciences in Bratislava, Comenius University, 841 04 Bratislava, Slovakia.ORCID 0009-0005-7259-704X
Milan GrofikClinic of Neurology, Martin University Hospital, 036 01 Martin, Slovakia.ORCID 0000-0003-0464-0497
Michaela ŠkorvanováBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, 036 01 Bratislava, Slovakia.ORCID 0009-0007-8472-3175
Jakub ŠofrankoBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, 036 01 Bratislava, Slovakia.
Nela ŽidekováBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, 036 01 Bratislava, Slovakia.ORCID 0009-0008-2878-5416
Egon KurčaClinic of Neurology, Martin University Hospital, 036 01 Martin, Slovakia.
Martin KolísekBiomedical Centre Martin, Jessenius Faculty of Medicine in Martin, Comenius University, 036 01 Bratislava, Slovakia.

Funding

Slovak Research and Development Agency APVV-19-0222.
6 · The paper itself

Abstract

Bile acids (BA) are increasingly recognized as signaling molecules involved in metabolic regulation and inflammatory processes, both of which are relevant to Parkinson's disease (PD). However, their role in PD and disease progression remains unclear. In this study, plasma BA profiles were analyzed in 113 participants, including early- and advanced-stage PD patients and age- and sex-matched controls, across three time points over three years. Targeted metabolomics using LC-MS was applied to quantify 20 BA, complemented by analyses of functional ratios, including unconjugated/conjugated and hydrophobic/hydrophilic BA ratios and correlation patterns between BA species. Although most individual BA did not show consistent longitudinal changes, pooled analysis identified significant differences in the unconjugated/conjugated BA ratio between PD patients and controls. In contrast, the hydrophobic/hydrophilic ratio did not differ significantly between groups. Correlation analysis revealed differences in selected BA interrelationships, particularly involving primary and secondary BA, while the overall network structure remained largely preserved. These results indicate that BA metabolism in PD might be characterized rather by subtle, distributed alterations than pronounced changes in individual metabolites. BA profiling may therefore contribute to a broader metabolic characterization of PD, but its utility as a standalone biomarker appears limited.

Indexed as

Bile Acids and SaltsParkinson DiseaseAgedFemaleHumansLongitudinal StudiesMaleMetabolomicsMiddle AgedBile Acids and Saltsbile acidsbiomarkersgut-brain axislongitudinal studyParkinson’s disease

Identifiers

PMID42352341
PMCPMC13297225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.